About The Position

Massive Bio is a health-tech company on a mission to give every cancer patient access to the right therapy and clinical trials. We build AI-powered products that remove friction between trial discovery and treatment. DUO (Drug Utilization Optimizer) is an AI-driven oncology platform that helps pharmaceutical companies shorten the path from trial discovery to patient treatment by identifying the right physicians, at the right moment, with real-time, consented patient insights. DUO is being embedded as a 'Launch Acceleration' standard across oncology portfolios.

Requirements

  • 5+ years in product management with strong technical depth (previous SWE/data experience ideal).
  • Proven delivery of data/AI products.
  • Experience integrating with enterprise systems (e.g., CRM, marketing automation, data platforms).
  • Demonstrated ability to define and instrument outcome-level metrics (e.g., physician alerts, diagnostic testing, referrals, NBRx) and tie product work to commercial lift.
  • Fluency in Agile/Scrum; strong PRD/spec writing and data skills.

Nice To Haves

  • Understand how oncology drugs go to market and how biomarker testing fits in.
  • Comfortable working with RWD providers and CRM/omnichannel tools.
  • Have helped roll out new solutions inside big pharma.

Responsibilities

  • Convert commercial use cases into clear product requirements, MVPs, and iterative releases that support DUO’s Trial to Launch Bridge and Launch Acceleration solutions.
  • Partner with leaders in Innovation, Market, Medical, Procurement, and Legal to validate problem statements and de-risk adoption paths in complex enterprise environments.
  • Define end-to-end architecture requirements including event pipelines, consent services, identity graphs, model scoring services, APIs, and observability.
  • Write crisp PRDs and technical specs; maintain a groomed backlog; drive Agile rituals; remove blockers.
  • Set and own product success metrics tied to DUO outcomes such as time from physician alert to action, diagnostic testing rates, and referral completion.
  • Establish data contracts and quality SLAs; manage training/feedback datasets with strict consent lineage.
  • Partner with Security/Compliance on HIPAA/GDPR-aligned consent management and PHI minimization.
  • Lead beta/early access programs that prove value rapidly; craft roll-out and enablement plans that scale to multi-brand, portfolio-level deployments.
  • Create the measurement framework and reporting that commercial teams can take to executive stakeholders, quantifying DUO’s impact on alerts, testing, and referrals.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service